nodes	percent_of_prediction	percent_of_DWPC	metapath
Medroxyprogesterone Acetate—Methylprednisolone—multiple sclerosis	0.234	1	CrCtD
Medroxyprogesterone Acetate—PGR—multiple sclerosis	0.137	1	CbGaD
Medroxyprogesterone Acetate—breast cancer—Betamethasone—multiple sclerosis	0.101	0.5	CpDpCtD
Medroxyprogesterone Acetate—breast cancer—Dexamethasone—multiple sclerosis	0.101	0.5	CpDpCtD
Medroxyprogesterone Acetate—PGR—Betamethasone—multiple sclerosis	0.027	0.178	CbGbCtD
Medroxyprogesterone Acetate—NR3C1—Methylprednisolone—multiple sclerosis	0.0212	0.14	CbGbCtD
Medroxyprogesterone Acetate—NR3C1—Triamcinolone—multiple sclerosis	0.0161	0.106	CbGbCtD
Medroxyprogesterone Acetate—PGR—Dexamethasone—multiple sclerosis	0.0157	0.104	CbGbCtD
Medroxyprogesterone Acetate—NR3C1—Betamethasone—multiple sclerosis	0.0138	0.091	CbGbCtD
Medroxyprogesterone Acetate—NR3C1—Prednisolone—multiple sclerosis	0.0136	0.0898	CbGbCtD
Medroxyprogesterone Acetate—NR3C1—Prednisone—multiple sclerosis	0.0128	0.0848	CbGbCtD
Medroxyprogesterone Acetate—NR3C1—Dexamethasone—multiple sclerosis	0.00802	0.0529	CbGbCtD
Medroxyprogesterone Acetate—Potassium Canrenoate—Prednisone—multiple sclerosis	0.00602	0.0292	CrCrCtD
Medroxyprogesterone Acetate—Potassium Canrenoate—Prednisolone—multiple sclerosis	0.00587	0.0285	CrCrCtD
Medroxyprogesterone Acetate—Medrysone—Methylprednisolone—multiple sclerosis	0.00557	0.027	CrCrCtD
Medroxyprogesterone Acetate—Flurandrenolide—Methylprednisolone—multiple sclerosis	0.00518	0.0251	CrCrCtD
Medroxyprogesterone Acetate—Flurandrenolide—Dexamethasone—multiple sclerosis	0.0051	0.0247	CrCrCtD
Medroxyprogesterone Acetate—Flurandrenolide—Betamethasone—multiple sclerosis	0.0051	0.0247	CrCrCtD
Medroxyprogesterone Acetate—Medrysone—Prednisolone—multiple sclerosis	0.00496	0.0241	CrCrCtD
Medroxyprogesterone Acetate—Hydrocortamate—Methylprednisolone—multiple sclerosis	0.00484	0.0235	CrCrCtD
Medroxyprogesterone Acetate—Cortisone acetate—Methylprednisolone—multiple sclerosis	0.00469	0.0228	CrCrCtD
Medroxyprogesterone Acetate—Flurandrenolide—Prednisolone—multiple sclerosis	0.00461	0.0224	CrCrCtD
Medroxyprogesterone Acetate—CYP3A4—Fingolimod—multiple sclerosis	0.00459	0.0303	CbGbCtD
Medroxyprogesterone Acetate—Prednicarbate—Methylprednisolone—multiple sclerosis	0.00455	0.0221	CrCrCtD
Medroxyprogesterone Acetate—Prednicarbate—Dexamethasone—multiple sclerosis	0.00448	0.0217	CrCrCtD
Medroxyprogesterone Acetate—Prednicarbate—Betamethasone—multiple sclerosis	0.00448	0.0217	CrCrCtD
Medroxyprogesterone Acetate—Hydrocortamate—Prednisone—multiple sclerosis	0.00442	0.0214	CrCrCtD
Medroxyprogesterone Acetate—Prednicarbate—Triamcinolone—multiple sclerosis	0.00438	0.0212	CrCrCtD
Medroxyprogesterone Acetate—Hydrocortamate—Prednisolone—multiple sclerosis	0.00431	0.0209	CrCrCtD
Medroxyprogesterone Acetate—Cortisone acetate—Prednisone—multiple sclerosis	0.00428	0.0208	CrCrCtD
Medroxyprogesterone Acetate—Cortisone acetate—Prednisolone—multiple sclerosis	0.00418	0.0203	CrCrCtD
Medroxyprogesterone Acetate—Prednicarbate—Prednisone—multiple sclerosis	0.00416	0.0202	CrCrCtD
Medroxyprogesterone Acetate—Fluoxymesterone—Betamethasone—multiple sclerosis	0.00412	0.02	CrCrCtD
Medroxyprogesterone Acetate—Fluoxymesterone—Dexamethasone—multiple sclerosis	0.00412	0.02	CrCrCtD
Medroxyprogesterone Acetate—Fludrocortisone—Methylprednisolone—multiple sclerosis	0.00408	0.0198	CrCrCtD
Medroxyprogesterone Acetate—Prednicarbate—Prednisolone—multiple sclerosis	0.00406	0.0197	CrCrCtD
Medroxyprogesterone Acetate—Fluoxymesterone—Triamcinolone—multiple sclerosis	0.00403	0.0195	CrCrCtD
Medroxyprogesterone Acetate—Fludrocortisone—Betamethasone—multiple sclerosis	0.00401	0.0195	CrCrCtD
Medroxyprogesterone Acetate—Fludrocortisone—Dexamethasone—multiple sclerosis	0.00401	0.0195	CrCrCtD
Medroxyprogesterone Acetate—Fludrocortisone—Triamcinolone—multiple sclerosis	0.00392	0.019	CrCrCtD
Medroxyprogesterone Acetate—Fluorometholone—Methylprednisolone—multiple sclerosis	0.00379	0.0184	CrCrCtD
Medroxyprogesterone Acetate—Fluoxymesterone—Prednisolone—multiple sclerosis	0.00373	0.0181	CrCrCtD
Medroxyprogesterone Acetate—Fluorometholone—Dexamethasone—multiple sclerosis	0.00373	0.0181	CrCrCtD
Medroxyprogesterone Acetate—Fluorometholone—Betamethasone—multiple sclerosis	0.00373	0.0181	CrCrCtD
Medroxyprogesterone Acetate—Fludrocortisone—Prednisone—multiple sclerosis	0.00372	0.0181	CrCrCtD
Medroxyprogesterone Acetate—Fluorometholone—Triamcinolone—multiple sclerosis	0.00364	0.0177	CrCrCtD
Medroxyprogesterone Acetate—Fludrocortisone—Prednisolone—multiple sclerosis	0.00363	0.0176	CrCrCtD
Medroxyprogesterone Acetate—Progesterone—Prednisolone—multiple sclerosis	0.00363	0.0176	CrCrCtD
Medroxyprogesterone Acetate—Methyltestosterone—Prednisone—multiple sclerosis	0.00363	0.0176	CrCrCtD
Medroxyprogesterone Acetate—Methyltestosterone—Prednisolone—multiple sclerosis	0.00354	0.0172	CrCrCtD
Medroxyprogesterone Acetate—Methylprednisolone—Dexamethasone—multiple sclerosis	0.00348	0.0169	CrCrCtD
Medroxyprogesterone Acetate—Methylprednisolone—Betamethasone—multiple sclerosis	0.00348	0.0169	CrCrCtD
Medroxyprogesterone Acetate—Fluorometholone—Prednisone—multiple sclerosis	0.00346	0.0168	CrCrCtD
Medroxyprogesterone Acetate—Methylprednisolone—Triamcinolone—multiple sclerosis	0.0034	0.0165	CrCrCtD
Medroxyprogesterone Acetate—Fluorometholone—Prednisolone—multiple sclerosis	0.00337	0.0164	CrCrCtD
Medroxyprogesterone Acetate—Hydrocortisone—Methylprednisolone—multiple sclerosis	0.00333	0.0161	CrCrCtD
Medroxyprogesterone Acetate—Hydrocortisone—Dexamethasone—multiple sclerosis	0.00327	0.0159	CrCrCtD
Medroxyprogesterone Acetate—Hydrocortisone—Betamethasone—multiple sclerosis	0.00327	0.0159	CrCrCtD
Medroxyprogesterone Acetate—Methylprednisolone—Prednisone—multiple sclerosis	0.00323	0.0157	CrCrCtD
Medroxyprogesterone Acetate—Hydrocortisone—Triamcinolone—multiple sclerosis	0.0032	0.0155	CrCrCtD
Medroxyprogesterone Acetate—Methylprednisolone—Prednisolone—multiple sclerosis	0.00315	0.0153	CrCrCtD
Medroxyprogesterone Acetate—Testosterone—Prednisolone—multiple sclerosis	0.00315	0.0153	CrCrCtD
Medroxyprogesterone Acetate—Hydrocortisone—Prednisone—multiple sclerosis	0.00304	0.0147	CrCrCtD
Medroxyprogesterone Acetate—Hydrocortisone—Prednisolone—multiple sclerosis	0.00296	0.0144	CrCrCtD
Medroxyprogesterone Acetate—CYP3A4—Methylprednisolone—multiple sclerosis	0.00296	0.0195	CbGbCtD
Medroxyprogesterone Acetate—CYP2C8—Dexamethasone—multiple sclerosis	0.00276	0.0182	CbGbCtD
Medroxyprogesterone Acetate—CYP3A4—Triamcinolone—multiple sclerosis	0.00224	0.0148	CbGbCtD
Medroxyprogesterone Acetate—CYP3A4—Mitoxantrone—multiple sclerosis	0.00216	0.0142	CbGbCtD
Medroxyprogesterone Acetate—CYP2C9—Dexamethasone—multiple sclerosis	0.00192	0.0127	CbGbCtD
Medroxyprogesterone Acetate—CYP3A4—Betamethasone—multiple sclerosis	0.00192	0.0127	CbGbCtD
Medroxyprogesterone Acetate—CYP3A4—Prednisolone—multiple sclerosis	0.0019	0.0125	CbGbCtD
Medroxyprogesterone Acetate—CYP3A4—Prednisone—multiple sclerosis	0.00179	0.0118	CbGbCtD
Medroxyprogesterone Acetate—CYP3A4—Dexamethasone—multiple sclerosis	0.00112	0.00738	CbGbCtD
Medroxyprogesterone Acetate—Dydrogesterone—PGR—multiple sclerosis	0.00029	0.248	CrCbGaD
Medroxyprogesterone Acetate—HSD3B2—nervous system—multiple sclerosis	0.000263	0.0812	CbGeAlD
Medroxyprogesterone Acetate—HSD3B2—central nervous system—multiple sclerosis	0.000253	0.0782	CbGeAlD
Medroxyprogesterone Acetate—Ethynodiol—PGR—multiple sclerosis	0.000239	0.204	CrCbGaD
Medroxyprogesterone Acetate—HSD3B2—brain—multiple sclerosis	0.000201	0.0621	CbGeAlD
Medroxyprogesterone Acetate—NR3C1—nerve—multiple sclerosis	0.000193	0.0595	CbGeAlD
Medroxyprogesterone Acetate—Megestrol acetate—PGR—multiple sclerosis	0.000175	0.149	CrCbGaD
Medroxyprogesterone Acetate—SHBG—brainstem—multiple sclerosis	0.000159	0.0492	CbGeAlD
Medroxyprogesterone Acetate—Drospirenone—PGR—multiple sclerosis	0.000152	0.13	CrCbGaD
Medroxyprogesterone Acetate—AKR1C3—medulla oblongata—multiple sclerosis	0.000148	0.0456	CbGeAlD
Medroxyprogesterone Acetate—AKR1C3—midbrain—multiple sclerosis	0.000135	0.0417	CbGeAlD
Medroxyprogesterone Acetate—AKR1C3—spinal cord—multiple sclerosis	0.000132	0.0407	CbGeAlD
Medroxyprogesterone Acetate—ESR1—brainstem—multiple sclerosis	0.000112	0.0346	CbGeAlD
Medroxyprogesterone Acetate—Spironolactone—PGR—multiple sclerosis	0.000109	0.0927	CrCbGaD
Medroxyprogesterone Acetate—AKR1C3—cerebellum—multiple sclerosis	0.000104	0.0322	CbGeAlD
Medroxyprogesterone Acetate—Drospirenone—BCHE—multiple sclerosis	0.000104	0.0892	CrCbGaD
Medroxyprogesterone Acetate—AKR1C3—brain—multiple sclerosis	8.49e-05	0.0262	CbGeAlD
Medroxyprogesterone Acetate—NR3C1—brainstem—multiple sclerosis	8.28e-05	0.0256	CbGeAlD
Medroxyprogesterone Acetate—SHBG—central nervous system—multiple sclerosis	8.03e-05	0.0248	CbGeAlD
Medroxyprogesterone Acetate—SHBG—cerebellum—multiple sclerosis	7.85e-05	0.0242	CbGeAlD
Medroxyprogesterone Acetate—PGR—nervous system—multiple sclerosis	7.52e-05	0.0232	CbGeAlD
Medroxyprogesterone Acetate—PGR—central nervous system—multiple sclerosis	7.24e-05	0.0223	CbGeAlD
Medroxyprogesterone Acetate—AR—spinal cord—multiple sclerosis	7.11e-05	0.0219	CbGeAlD
Medroxyprogesterone Acetate—PGR—cerebellum—multiple sclerosis	7.07e-05	0.0218	CbGeAlD
Medroxyprogesterone Acetate—SHBG—brain—multiple sclerosis	6.38e-05	0.0197	CbGeAlD
Medroxyprogesterone Acetate—AR—nervous system—multiple sclerosis	5.99e-05	0.0185	CbGeAlD
Medroxyprogesterone Acetate—ESR1—nervous system—multiple sclerosis	5.88e-05	0.0181	CbGeAlD
Medroxyprogesterone Acetate—Progesterone—PGR—multiple sclerosis	5.87e-05	0.0502	CrCbGaD
Medroxyprogesterone Acetate—NR3C1—medulla oblongata—multiple sclerosis	5.77e-05	0.0178	CbGeAlD
Medroxyprogesterone Acetate—AR—central nervous system—multiple sclerosis	5.77e-05	0.0178	CbGeAlD
Medroxyprogesterone Acetate—PGR—brain—multiple sclerosis	5.75e-05	0.0177	CbGeAlD
Medroxyprogesterone Acetate—ESR1—central nervous system—multiple sclerosis	5.66e-05	0.0175	CbGeAlD
Medroxyprogesterone Acetate—ESR1—cerebellum—multiple sclerosis	5.53e-05	0.0171	CbGeAlD
Medroxyprogesterone Acetate—NR3C1—midbrain—multiple sclerosis	5.28e-05	0.0163	CbGeAlD
Medroxyprogesterone Acetate—NR3C1—spinal cord—multiple sclerosis	5.15e-05	0.0159	CbGeAlD
Medroxyprogesterone Acetate—AR—brain—multiple sclerosis	4.58e-05	0.0141	CbGeAlD
Medroxyprogesterone Acetate—ESR1—brain—multiple sclerosis	4.49e-05	0.0139	CbGeAlD
Medroxyprogesterone Acetate—NR3C1—nervous system—multiple sclerosis	4.34e-05	0.0134	CbGeAlD
Medroxyprogesterone Acetate—NR3C1—central nervous system—multiple sclerosis	4.18e-05	0.0129	CbGeAlD
Medroxyprogesterone Acetate—NR3C1—cerebellum—multiple sclerosis	4.08e-05	0.0126	CbGeAlD
Medroxyprogesterone Acetate—CYP2C8—brain—multiple sclerosis	3.7e-05	0.0114	CbGeAlD
Medroxyprogesterone Acetate—NR3C1—brain—multiple sclerosis	3.32e-05	0.0102	CbGeAlD
Medroxyprogesterone Acetate—CYP3A4—nervous system—multiple sclerosis	3.28e-05	0.0101	CbGeAlD
Medroxyprogesterone Acetate—CYP3A4—central nervous system—multiple sclerosis	3.16e-05	0.00975	CbGeAlD
Medroxyprogesterone Acetate—Methyltestosterone—ALB—multiple sclerosis	2.69e-05	0.023	CrCbGaD
Medroxyprogesterone Acetate—Alopecia—Prednisone—multiple sclerosis	1.95e-05	0.000401	CcSEcCtD
Medroxyprogesterone Acetate—Shock—Methylprednisolone—multiple sclerosis	1.95e-05	0.000401	CcSEcCtD
Medroxyprogesterone Acetate—Hepatobiliary disease—Methotrexate—multiple sclerosis	1.94e-05	0.0004	CcSEcCtD
Medroxyprogesterone Acetate—Nervous system disorder—Methylprednisolone—multiple sclerosis	1.94e-05	0.000399	CcSEcCtD
Medroxyprogesterone Acetate—Loss of consciousness—Dexamethasone—multiple sclerosis	1.94e-05	0.000399	CcSEcCtD
Medroxyprogesterone Acetate—Loss of consciousness—Betamethasone—multiple sclerosis	1.94e-05	0.000399	CcSEcCtD
Medroxyprogesterone Acetate—Epistaxis—Methotrexate—multiple sclerosis	1.94e-05	0.000399	CcSEcCtD
Medroxyprogesterone Acetate—Hypersensitivity—Mitoxantrone—multiple sclerosis	1.94e-05	0.000399	CcSEcCtD
Medroxyprogesterone Acetate—Paraesthesia—Prednisolone—multiple sclerosis	1.94e-05	0.000399	CcSEcCtD
Medroxyprogesterone Acetate—Tachycardia—Triamcinolone—multiple sclerosis	1.94e-05	0.000398	CcSEcCtD
Medroxyprogesterone Acetate—Mental disorder—Prednisone—multiple sclerosis	1.93e-05	0.000398	CcSEcCtD
Medroxyprogesterone Acetate—Nausea—Azathioprine—multiple sclerosis	1.93e-05	0.000397	CcSEcCtD
Medroxyprogesterone Acetate—Tachycardia—Methylprednisolone—multiple sclerosis	1.93e-05	0.000397	CcSEcCtD
Medroxyprogesterone Acetate—Skin disorder—Methylprednisolone—multiple sclerosis	1.92e-05	0.000396	CcSEcCtD
Medroxyprogesterone Acetate—Malnutrition—Prednisone—multiple sclerosis	1.92e-05	0.000395	CcSEcCtD
Medroxyprogesterone Acetate—Erythema—Prednisone—multiple sclerosis	1.92e-05	0.000395	CcSEcCtD
Medroxyprogesterone Acetate—Hyperhidrosis—Triamcinolone—multiple sclerosis	1.92e-05	0.000395	CcSEcCtD
Medroxyprogesterone Acetate—Hyperhidrosis—Methylprednisolone—multiple sclerosis	1.91e-05	0.000394	CcSEcCtD
Medroxyprogesterone Acetate—Convulsion—Betamethasone—multiple sclerosis	1.91e-05	0.000393	CcSEcCtD
Medroxyprogesterone Acetate—Convulsion—Dexamethasone—multiple sclerosis	1.91e-05	0.000393	CcSEcCtD
Medroxyprogesterone Acetate—Asthenia—Mitoxantrone—multiple sclerosis	1.89e-05	0.000388	CcSEcCtD
Medroxyprogesterone Acetate—Myalgia—Betamethasone—multiple sclerosis	1.88e-05	0.000386	CcSEcCtD
Medroxyprogesterone Acetate—Myalgia—Dexamethasone—multiple sclerosis	1.88e-05	0.000386	CcSEcCtD
Medroxyprogesterone Acetate—Anxiety—Dexamethasone—multiple sclerosis	1.87e-05	0.000385	CcSEcCtD
Medroxyprogesterone Acetate—Anxiety—Betamethasone—multiple sclerosis	1.87e-05	0.000385	CcSEcCtD
Medroxyprogesterone Acetate—Discomfort—Betamethasone—multiple sclerosis	1.86e-05	0.000382	CcSEcCtD
Medroxyprogesterone Acetate—Discomfort—Dexamethasone—multiple sclerosis	1.86e-05	0.000382	CcSEcCtD
Medroxyprogesterone Acetate—Haemoglobin—Methotrexate—multiple sclerosis	1.85e-05	0.000381	CcSEcCtD
Medroxyprogesterone Acetate—Hypotension—Methylprednisolone—multiple sclerosis	1.85e-05	0.000381	CcSEcCtD
Medroxyprogesterone Acetate—Haemorrhage—Methotrexate—multiple sclerosis	1.84e-05	0.000379	CcSEcCtD
Medroxyprogesterone Acetate—Hepatitis—Methotrexate—multiple sclerosis	1.84e-05	0.000379	CcSEcCtD
Medroxyprogesterone Acetate—Pharyngitis—Methotrexate—multiple sclerosis	1.83e-05	0.000377	CcSEcCtD
Medroxyprogesterone Acetate—Urinary tract disorder—Methotrexate—multiple sclerosis	1.82e-05	0.000375	CcSEcCtD
Medroxyprogesterone Acetate—Urethral disorder—Methotrexate—multiple sclerosis	1.81e-05	0.000372	CcSEcCtD
Medroxyprogesterone Acetate—Musculoskeletal discomfort—Triamcinolone—multiple sclerosis	1.81e-05	0.000372	CcSEcCtD
Medroxyprogesterone Acetate—Musculoskeletal discomfort—Methylprednisolone—multiple sclerosis	1.8e-05	0.000371	CcSEcCtD
Medroxyprogesterone Acetate—Anaphylactic shock—Betamethasone—multiple sclerosis	1.8e-05	0.00037	CcSEcCtD
Medroxyprogesterone Acetate—Anaphylactic shock—Dexamethasone—multiple sclerosis	1.8e-05	0.00037	CcSEcCtD
Medroxyprogesterone Acetate—Oedema—Dexamethasone—multiple sclerosis	1.8e-05	0.00037	CcSEcCtD
Medroxyprogesterone Acetate—Oedema—Betamethasone—multiple sclerosis	1.8e-05	0.00037	CcSEcCtD
Medroxyprogesterone Acetate—Diarrhoea—Mitoxantrone—multiple sclerosis	1.8e-05	0.00037	CcSEcCtD
Medroxyprogesterone Acetate—Insomnia—Triamcinolone—multiple sclerosis	1.79e-05	0.000369	CcSEcCtD
Medroxyprogesterone Acetate—Insomnia—Methylprednisolone—multiple sclerosis	1.79e-05	0.000368	CcSEcCtD
Medroxyprogesterone Acetate—Infection—Dexamethasone—multiple sclerosis	1.79e-05	0.000368	CcSEcCtD
Medroxyprogesterone Acetate—Infection—Betamethasone—multiple sclerosis	1.79e-05	0.000368	CcSEcCtD
Medroxyprogesterone Acetate—Ill-defined disorder—Prednisone—multiple sclerosis	1.78e-05	0.000367	CcSEcCtD
Medroxyprogesterone Acetate—Paraesthesia—Triamcinolone—multiple sclerosis	1.78e-05	0.000366	CcSEcCtD
Medroxyprogesterone Acetate—Feeling abnormal—Prednisolone—multiple sclerosis	1.78e-05	0.000366	CcSEcCtD
Medroxyprogesterone Acetate—Paraesthesia—Methylprednisolone—multiple sclerosis	1.78e-05	0.000366	CcSEcCtD
Medroxyprogesterone Acetate—Visual impairment—Methotrexate—multiple sclerosis	1.78e-05	0.000366	CcSEcCtD
Medroxyprogesterone Acetate—Anaemia—Prednisone—multiple sclerosis	1.78e-05	0.000365	CcSEcCtD
Medroxyprogesterone Acetate—Shock—Dexamethasone—multiple sclerosis	1.77e-05	0.000364	CcSEcCtD
Medroxyprogesterone Acetate—Shock—Betamethasone—multiple sclerosis	1.77e-05	0.000364	CcSEcCtD
Medroxyprogesterone Acetate—Dyspnoea—Triamcinolone—multiple sclerosis	1.77e-05	0.000364	CcSEcCtD
Medroxyprogesterone Acetate—Nervous system disorder—Betamethasone—multiple sclerosis	1.77e-05	0.000363	CcSEcCtD
Medroxyprogesterone Acetate—Nervous system disorder—Dexamethasone—multiple sclerosis	1.77e-05	0.000363	CcSEcCtD
Medroxyprogesterone Acetate—Agitation—Prednisone—multiple sclerosis	1.77e-05	0.000363	CcSEcCtD
Medroxyprogesterone Acetate—Thrombocytopenia—Dexamethasone—multiple sclerosis	1.76e-05	0.000363	CcSEcCtD
Medroxyprogesterone Acetate—Thrombocytopenia—Betamethasone—multiple sclerosis	1.76e-05	0.000363	CcSEcCtD
Medroxyprogesterone Acetate—Tachycardia—Dexamethasone—multiple sclerosis	1.76e-05	0.000361	CcSEcCtD
Medroxyprogesterone Acetate—Tachycardia—Betamethasone—multiple sclerosis	1.76e-05	0.000361	CcSEcCtD
Medroxyprogesterone Acetate—Angioedema—Prednisone—multiple sclerosis	1.76e-05	0.000361	CcSEcCtD
Medroxyprogesterone Acetate—Dyspepsia—Triamcinolone—multiple sclerosis	1.75e-05	0.000359	CcSEcCtD
Medroxyprogesterone Acetate—Erythema multiforme—Methotrexate—multiple sclerosis	1.74e-05	0.000359	CcSEcCtD
Medroxyprogesterone Acetate—Dyspepsia—Methylprednisolone—multiple sclerosis	1.74e-05	0.000358	CcSEcCtD
Medroxyprogesterone Acetate—Hyperhidrosis—Betamethasone—multiple sclerosis	1.74e-05	0.000358	CcSEcCtD
Medroxyprogesterone Acetate—Hyperhidrosis—Dexamethasone—multiple sclerosis	1.74e-05	0.000358	CcSEcCtD
Medroxyprogesterone Acetate—Malaise—Prednisone—multiple sclerosis	1.73e-05	0.000356	CcSEcCtD
Medroxyprogesterone Acetate—Vertigo—Prednisone—multiple sclerosis	1.73e-05	0.000355	CcSEcCtD
Medroxyprogesterone Acetate—Eye disorder—Methotrexate—multiple sclerosis	1.72e-05	0.000355	CcSEcCtD
Medroxyprogesterone Acetate—Syncope—Prednisone—multiple sclerosis	1.72e-05	0.000354	CcSEcCtD
Medroxyprogesterone Acetate—Tinnitus—Methotrexate—multiple sclerosis	1.72e-05	0.000354	CcSEcCtD
Medroxyprogesterone Acetate—Anorexia—Dexamethasone—multiple sclerosis	1.72e-05	0.000353	CcSEcCtD
Medroxyprogesterone Acetate—Anorexia—Betamethasone—multiple sclerosis	1.72e-05	0.000353	CcSEcCtD
Medroxyprogesterone Acetate—Urticaria—Prednisolone—multiple sclerosis	1.71e-05	0.000353	CcSEcCtD
Medroxyprogesterone Acetate—Cardiac disorder—Methotrexate—multiple sclerosis	1.71e-05	0.000352	CcSEcCtD
Medroxyprogesterone Acetate—Fatigue—Triamcinolone—multiple sclerosis	1.71e-05	0.000352	CcSEcCtD
Medroxyprogesterone Acetate—Fatigue—Methylprednisolone—multiple sclerosis	1.71e-05	0.000351	CcSEcCtD
Medroxyprogesterone Acetate—AKR1C3—Signaling Pathways—GPC5—multiple sclerosis	1.7e-05	0.00104	CbGpPWpGaD
Medroxyprogesterone Acetate—Loss of consciousness—Prednisone—multiple sclerosis	1.69e-05	0.000347	CcSEcCtD
Medroxyprogesterone Acetate—AKR1C3—Metabolism—RRM1—multiple sclerosis	1.69e-05	0.00103	CbGpPWpGaD
Medroxyprogesterone Acetate—Hypotension—Dexamethasone—multiple sclerosis	1.68e-05	0.000346	CcSEcCtD
Medroxyprogesterone Acetate—Hypotension—Betamethasone—multiple sclerosis	1.68e-05	0.000346	CcSEcCtD
Medroxyprogesterone Acetate—Angiopathy—Methotrexate—multiple sclerosis	1.67e-05	0.000344	CcSEcCtD
Medroxyprogesterone Acetate—Vomiting—Mitoxantrone—multiple sclerosis	1.67e-05	0.000344	CcSEcCtD
Medroxyprogesterone Acetate—AR—Generic Transcription Pathway—PGR—multiple sclerosis	1.67e-05	0.00102	CbGpPWpGaD
Medroxyprogesterone Acetate—Immune system disorder—Methotrexate—multiple sclerosis	1.67e-05	0.000343	CcSEcCtD
Medroxyprogesterone Acetate—Convulsion—Prednisone—multiple sclerosis	1.66e-05	0.000342	CcSEcCtD
Medroxyprogesterone Acetate—Mediastinal disorder—Methotrexate—multiple sclerosis	1.66e-05	0.000342	CcSEcCtD
Medroxyprogesterone Acetate—Rash—Mitoxantrone—multiple sclerosis	1.66e-05	0.000341	CcSEcCtD
Medroxyprogesterone Acetate—Dermatitis—Mitoxantrone—multiple sclerosis	1.66e-05	0.000341	CcSEcCtD
Medroxyprogesterone Acetate—Chills—Methotrexate—multiple sclerosis	1.66e-05	0.00034	CcSEcCtD
Medroxyprogesterone Acetate—Headache—Mitoxantrone—multiple sclerosis	1.65e-05	0.000339	CcSEcCtD
Medroxyprogesterone Acetate—ESR1—Regulation of Telomerase—MYC—multiple sclerosis	1.65e-05	0.00101	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Regulation of Telomerase—TGFB1—multiple sclerosis	1.64e-05	0.001	CbGpPWpGaD
Medroxyprogesterone Acetate—Musculoskeletal discomfort—Dexamethasone—multiple sclerosis	1.64e-05	0.000337	CcSEcCtD
Medroxyprogesterone Acetate—Musculoskeletal discomfort—Betamethasone—multiple sclerosis	1.64e-05	0.000337	CcSEcCtD
Medroxyprogesterone Acetate—ESR1—Leptin signaling pathway—STAT3—multiple sclerosis	1.64e-05	0.001	CbGpPWpGaD
Medroxyprogesterone Acetate—Arthralgia—Prednisone—multiple sclerosis	1.64e-05	0.000336	CcSEcCtD
Medroxyprogesterone Acetate—Myalgia—Prednisone—multiple sclerosis	1.64e-05	0.000336	CcSEcCtD
Medroxyprogesterone Acetate—Feeling abnormal—Triamcinolone—multiple sclerosis	1.64e-05	0.000336	CcSEcCtD
Medroxyprogesterone Acetate—Feeling abnormal—Methylprednisolone—multiple sclerosis	1.63e-05	0.000336	CcSEcCtD
Medroxyprogesterone Acetate—Anxiety—Prednisone—multiple sclerosis	1.63e-05	0.000335	CcSEcCtD
Medroxyprogesterone Acetate—Alopecia—Methotrexate—multiple sclerosis	1.63e-05	0.000335	CcSEcCtD
Medroxyprogesterone Acetate—Insomnia—Dexamethasone—multiple sclerosis	1.63e-05	0.000335	CcSEcCtD
Medroxyprogesterone Acetate—Insomnia—Betamethasone—multiple sclerosis	1.63e-05	0.000335	CcSEcCtD
Medroxyprogesterone Acetate—Unspecified disorder of skin and subcutaneous tissue—Prednisone—multiple sclerosis	1.62e-05	0.000334	CcSEcCtD
Medroxyprogesterone Acetate—Gastrointestinal pain—Methylprednisolone—multiple sclerosis	1.62e-05	0.000333	CcSEcCtD
Medroxyprogesterone Acetate—Paraesthesia—Dexamethasone—multiple sclerosis	1.62e-05	0.000333	CcSEcCtD
Medroxyprogesterone Acetate—Paraesthesia—Betamethasone—multiple sclerosis	1.62e-05	0.000333	CcSEcCtD
Medroxyprogesterone Acetate—NR3C1—Endoderm Differentiation—TGFB1—multiple sclerosis	1.62e-05	0.000988	CbGpPWpGaD
Medroxyprogesterone Acetate—Discomfort—Prednisone—multiple sclerosis	1.62e-05	0.000332	CcSEcCtD
Medroxyprogesterone Acetate—Mental disorder—Methotrexate—multiple sclerosis	1.62e-05	0.000332	CcSEcCtD
Medroxyprogesterone Acetate—ESR1—Regulation of Telomerase—MAPK1—multiple sclerosis	1.61e-05	0.000984	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—AP-1 transcription factor network—MYC—multiple sclerosis	1.61e-05	0.000983	CbGpPWpGaD
Medroxyprogesterone Acetate—Malnutrition—Methotrexate—multiple sclerosis	1.61e-05	0.00033	CcSEcCtD
Medroxyprogesterone Acetate—Erythema—Methotrexate—multiple sclerosis	1.61e-05	0.00033	CcSEcCtD
Medroxyprogesterone Acetate—ESR1—AP-1 transcription factor network—TGFB1—multiple sclerosis	1.6e-05	0.00098	CbGpPWpGaD
Medroxyprogesterone Acetate—Hypersensitivity—Prednisolone—multiple sclerosis	1.59e-05	0.000327	CcSEcCtD
Medroxyprogesterone Acetate—Dyspepsia—Dexamethasone—multiple sclerosis	1.59e-05	0.000326	CcSEcCtD
Medroxyprogesterone Acetate—Dyspepsia—Betamethasone—multiple sclerosis	1.59e-05	0.000326	CcSEcCtD
Medroxyprogesterone Acetate—NR3C1—AP-1 transcription factor network—MYC—multiple sclerosis	1.58e-05	0.000968	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Integrated Pancreatic Cancer Pathway—FAS—multiple sclerosis	1.58e-05	0.000966	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Disease—RPL5—multiple sclerosis	1.58e-05	0.000966	CbGpPWpGaD
Medroxyprogesterone Acetate—NR3C1—AP-1 transcription factor network—TGFB1—multiple sclerosis	1.58e-05	0.000966	CbGpPWpGaD
Medroxyprogesterone Acetate—PGR—Signaling Pathways—TAGAP—multiple sclerosis	1.58e-05	0.000965	CbGpPWpGaD
Medroxyprogesterone Acetate—Urticaria—Triamcinolone—multiple sclerosis	1.58e-05	0.000324	CcSEcCtD
Medroxyprogesterone Acetate—ESR1—Signaling by ERBB4—CD80—multiple sclerosis	1.57e-05	0.000962	CbGpPWpGaD
Medroxyprogesterone Acetate—Urticaria—Methylprednisolone—multiple sclerosis	1.57e-05	0.000324	CcSEcCtD
Medroxyprogesterone Acetate—Dysgeusia—Methotrexate—multiple sclerosis	1.57e-05	0.000323	CcSEcCtD
Medroxyprogesterone Acetate—Body temperature increased—Triamcinolone—multiple sclerosis	1.57e-05	0.000323	CcSEcCtD
Medroxyprogesterone Acetate—Oedema—Prednisone—multiple sclerosis	1.57e-05	0.000323	CcSEcCtD
Medroxyprogesterone Acetate—Anaphylactic shock—Prednisone—multiple sclerosis	1.57e-05	0.000323	CcSEcCtD
Medroxyprogesterone Acetate—Abdominal pain—Methylprednisolone—multiple sclerosis	1.57e-05	0.000322	CcSEcCtD
Medroxyprogesterone Acetate—Decreased appetite—Dexamethasone—multiple sclerosis	1.57e-05	0.000322	CcSEcCtD
Medroxyprogesterone Acetate—Decreased appetite—Betamethasone—multiple sclerosis	1.57e-05	0.000322	CcSEcCtD
Medroxyprogesterone Acetate—Nausea—Mitoxantrone—multiple sclerosis	1.56e-05	0.000321	CcSEcCtD
Medroxyprogesterone Acetate—Testosterone—ALB—multiple sclerosis	1.56e-05	0.0133	CrCbGaD
Medroxyprogesterone Acetate—Infection—Prednisone—multiple sclerosis	1.56e-05	0.00032	CcSEcCtD
Medroxyprogesterone Acetate—CYP2C9—Cytochrome P450 - arranged by substrate type—POMC—multiple sclerosis	1.55e-05	0.000951	CbGpPWpGaD
Medroxyprogesterone Acetate—Gastrointestinal disorder—Dexamethasone—multiple sclerosis	1.55e-05	0.00032	CcSEcCtD
Medroxyprogesterone Acetate—Gastrointestinal disorder—Betamethasone—multiple sclerosis	1.55e-05	0.00032	CcSEcCtD
Medroxyprogesterone Acetate—Back pain—Methotrexate—multiple sclerosis	1.55e-05	0.000319	CcSEcCtD
Medroxyprogesterone Acetate—Fatigue—Betamethasone—multiple sclerosis	1.55e-05	0.000319	CcSEcCtD
Medroxyprogesterone Acetate—Fatigue—Dexamethasone—multiple sclerosis	1.55e-05	0.000319	CcSEcCtD
Medroxyprogesterone Acetate—CYP2C8—Phase 1 - Functionalization of compounds—POMC—multiple sclerosis	1.55e-05	0.000947	CbGpPWpGaD
Medroxyprogesterone Acetate—Shock—Prednisone—multiple sclerosis	1.54e-05	0.000317	CcSEcCtD
Medroxyprogesterone Acetate—Nervous system disorder—Prednisone—multiple sclerosis	1.54e-05	0.000316	CcSEcCtD
Medroxyprogesterone Acetate—PGR—Generic Transcription Pathway—VDR—multiple sclerosis	1.53e-05	0.000938	CbGpPWpGaD
Medroxyprogesterone Acetate—Tachycardia—Prednisone—multiple sclerosis	1.53e-05	0.000315	CcSEcCtD
Medroxyprogesterone Acetate—Skin disorder—Prednisone—multiple sclerosis	1.52e-05	0.000313	CcSEcCtD
Medroxyprogesterone Acetate—Hyperhidrosis—Prednisone—multiple sclerosis	1.52e-05	0.000312	CcSEcCtD
Medroxyprogesterone Acetate—AKR1C3—Disease—SLC11A1—multiple sclerosis	1.51e-05	0.000925	CbGpPWpGaD
Medroxyprogesterone Acetate—Anorexia—Prednisone—multiple sclerosis	1.49e-05	0.000307	CcSEcCtD
Medroxyprogesterone Acetate—Ill-defined disorder—Methotrexate—multiple sclerosis	1.49e-05	0.000306	CcSEcCtD
Medroxyprogesterone Acetate—ESR1—Leptin signaling pathway—MAPK1—multiple sclerosis	1.49e-05	0.00091	CbGpPWpGaD
Medroxyprogesterone Acetate—PGR—Gene Expression—PABPC1—multiple sclerosis	1.49e-05	0.00091	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Signaling Pathways—RGS1—multiple sclerosis	1.49e-05	0.000909	CbGpPWpGaD
Medroxyprogesterone Acetate—Anaemia—Methotrexate—multiple sclerosis	1.48e-05	0.000305	CcSEcCtD
Medroxyprogesterone Acetate—Feeling abnormal—Dexamethasone—multiple sclerosis	1.48e-05	0.000305	CcSEcCtD
Medroxyprogesterone Acetate—Feeling abnormal—Betamethasone—multiple sclerosis	1.48e-05	0.000305	CcSEcCtD
Medroxyprogesterone Acetate—Gastrointestinal pain—Betamethasone—multiple sclerosis	1.47e-05	0.000303	CcSEcCtD
Medroxyprogesterone Acetate—Gastrointestinal pain—Dexamethasone—multiple sclerosis	1.47e-05	0.000303	CcSEcCtD
Medroxyprogesterone Acetate—Hypersensitivity—Triamcinolone—multiple sclerosis	1.46e-05	0.000301	CcSEcCtD
Medroxyprogesterone Acetate—AR—Gene Expression—ZFP36L1—multiple sclerosis	1.46e-05	0.000894	CbGpPWpGaD
Medroxyprogesterone Acetate—Hypersensitivity—Methylprednisolone—multiple sclerosis	1.46e-05	0.0003	CcSEcCtD
Medroxyprogesterone Acetate—Malaise—Methotrexate—multiple sclerosis	1.45e-05	0.000298	CcSEcCtD
Medroxyprogesterone Acetate—Vertigo—Methotrexate—multiple sclerosis	1.44e-05	0.000297	CcSEcCtD
Medroxyprogesterone Acetate—PGR—Signaling by ERBB4—MAPK1—multiple sclerosis	1.44e-05	0.000881	CbGpPWpGaD
Medroxyprogesterone Acetate—Urticaria—Dexamethasone—multiple sclerosis	1.43e-05	0.000294	CcSEcCtD
Medroxyprogesterone Acetate—Urticaria—Betamethasone—multiple sclerosis	1.43e-05	0.000294	CcSEcCtD
Medroxyprogesterone Acetate—ESR1—Regulation of nuclear SMAD2/3 signaling—MYC—multiple sclerosis	1.43e-05	0.000875	CbGpPWpGaD
Medroxyprogesterone Acetate—Musculoskeletal discomfort—Prednisone—multiple sclerosis	1.43e-05	0.000294	CcSEcCtD
Medroxyprogesterone Acetate—Dizziness—Prednisolone—multiple sclerosis	1.43e-05	0.000293	CcSEcCtD
Medroxyprogesterone Acetate—ESR1—Gene Expression—U2AF2—multiple sclerosis	1.42e-05	0.000871	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Gene Expression—HNRNPA1—multiple sclerosis	1.42e-05	0.000871	CbGpPWpGaD
Medroxyprogesterone Acetate—Asthenia—Triamcinolone—multiple sclerosis	1.42e-05	0.000293	CcSEcCtD
Medroxyprogesterone Acetate—Body temperature increased—Dexamethasone—multiple sclerosis	1.42e-05	0.000293	CcSEcCtD
Medroxyprogesterone Acetate—Abdominal pain—Betamethasone—multiple sclerosis	1.42e-05	0.000293	CcSEcCtD
Medroxyprogesterone Acetate—Abdominal pain—Dexamethasone—multiple sclerosis	1.42e-05	0.000293	CcSEcCtD
Medroxyprogesterone Acetate—Body temperature increased—Betamethasone—multiple sclerosis	1.42e-05	0.000293	CcSEcCtD
Medroxyprogesterone Acetate—Asthenia—Methylprednisolone—multiple sclerosis	1.42e-05	0.000292	CcSEcCtD
Medroxyprogesterone Acetate—Insomnia—Prednisone—multiple sclerosis	1.42e-05	0.000292	CcSEcCtD
Medroxyprogesterone Acetate—AR—SIDS Susceptibility Pathways—IL1B—multiple sclerosis	1.41e-05	0.000863	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Signaling Pathways—GPR65—multiple sclerosis	1.41e-05	0.000862	CbGpPWpGaD
Medroxyprogesterone Acetate—NR3C1—Regulation of nuclear SMAD2/3 signaling—MYC—multiple sclerosis	1.41e-05	0.000861	CbGpPWpGaD
Medroxyprogesterone Acetate—Paraesthesia—Prednisone—multiple sclerosis	1.41e-05	0.00029	CcSEcCtD
Medroxyprogesterone Acetate—CYP2C8—Metabolism of lipids and lipoproteins—CYP24A1—multiple sclerosis	1.4e-05	0.000859	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C8—Metabolism of lipids and lipoproteins—CYP27B1—multiple sclerosis	1.4e-05	0.000859	CbGpPWpGaD
Medroxyprogesterone Acetate—Pruritus—Triamcinolone—multiple sclerosis	1.4e-05	0.000289	CcSEcCtD
Medroxyprogesterone Acetate—NR3C1—Gene Expression—HNRNPA1—multiple sclerosis	1.4e-05	0.000858	CbGpPWpGaD
Medroxyprogesterone Acetate—NR3C1—Gene Expression—U2AF2—multiple sclerosis	1.4e-05	0.000858	CbGpPWpGaD
Medroxyprogesterone Acetate—Pruritus—Methylprednisolone—multiple sclerosis	1.4e-05	0.000288	CcSEcCtD
Medroxyprogesterone Acetate—Convulsion—Methotrexate—multiple sclerosis	1.39e-05	0.000286	CcSEcCtD
Medroxyprogesterone Acetate—ESR1—ATF-2 transcription factor network—IL6—multiple sclerosis	1.39e-05	0.000847	CbGpPWpGaD
Medroxyprogesterone Acetate—Dyspepsia—Prednisone—multiple sclerosis	1.38e-05	0.000284	CcSEcCtD
Medroxyprogesterone Acetate—PGR—Signaling Pathways—S1PR1—multiple sclerosis	1.38e-05	0.000843	CbGpPWpGaD
Medroxyprogesterone Acetate—Chest pain—Methotrexate—multiple sclerosis	1.37e-05	0.000281	CcSEcCtD
Medroxyprogesterone Acetate—Arthralgia—Methotrexate—multiple sclerosis	1.37e-05	0.000281	CcSEcCtD
Medroxyprogesterone Acetate—Myalgia—Methotrexate—multiple sclerosis	1.37e-05	0.000281	CcSEcCtD
Medroxyprogesterone Acetate—NR3C1—Glucocorticoid receptor regulatory network—MAPK1—multiple sclerosis	1.36e-05	0.000834	CbGpPWpGaD
Medroxyprogesterone Acetate—Decreased appetite—Prednisone—multiple sclerosis	1.36e-05	0.00028	CcSEcCtD
Medroxyprogesterone Acetate—Rash—Prednisolone—multiple sclerosis	1.36e-05	0.00028	CcSEcCtD
Medroxyprogesterone Acetate—Dermatitis—Prednisolone—multiple sclerosis	1.36e-05	0.00028	CcSEcCtD
Medroxyprogesterone Acetate—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—multiple sclerosis	1.36e-05	0.000279	CcSEcCtD
Medroxyprogesterone Acetate—Diarrhoea—Methylprednisolone—multiple sclerosis	1.35e-05	0.000279	CcSEcCtD
Medroxyprogesterone Acetate—Fatigue—Prednisone—multiple sclerosis	1.35e-05	0.000278	CcSEcCtD
Medroxyprogesterone Acetate—Headache—Prednisolone—multiple sclerosis	1.35e-05	0.000278	CcSEcCtD
Medroxyprogesterone Acetate—Discomfort—Methotrexate—multiple sclerosis	1.35e-05	0.000278	CcSEcCtD
Medroxyprogesterone Acetate—PGR—Gene Expression—RPL5—multiple sclerosis	1.34e-05	0.000821	CbGpPWpGaD
Medroxyprogesterone Acetate—PGR—Signaling Pathways—GPC5—multiple sclerosis	1.34e-05	0.000821	CbGpPWpGaD
Medroxyprogesterone Acetate—Constipation—Prednisone—multiple sclerosis	1.34e-05	0.000276	CcSEcCtD
Medroxyprogesterone Acetate—ESR1—Signaling by ERBB4—TYK2—multiple sclerosis	1.33e-05	0.000812	CbGpPWpGaD
Medroxyprogesterone Acetate—Confusional state—Methotrexate—multiple sclerosis	1.32e-05	0.000272	CcSEcCtD
Medroxyprogesterone Acetate—Dizziness—Triamcinolone—multiple sclerosis	1.31e-05	0.00027	CcSEcCtD
Medroxyprogesterone Acetate—Anaphylactic shock—Methotrexate—multiple sclerosis	1.31e-05	0.00027	CcSEcCtD
Medroxyprogesterone Acetate—Dizziness—Methylprednisolone—multiple sclerosis	1.31e-05	0.000269	CcSEcCtD
Medroxyprogesterone Acetate—AKR1C3—Metabolism of lipids and lipoproteins—APOE—multiple sclerosis	1.31e-05	0.0008	CbGpPWpGaD
Medroxyprogesterone Acetate—Infection—Methotrexate—multiple sclerosis	1.3e-05	0.000268	CcSEcCtD
Medroxyprogesterone Acetate—Feeling abnormal—Prednisone—multiple sclerosis	1.29e-05	0.000266	CcSEcCtD
Medroxyprogesterone Acetate—Asthenia—Dexamethasone—multiple sclerosis	1.29e-05	0.000266	CcSEcCtD
Medroxyprogesterone Acetate—Asthenia—Betamethasone—multiple sclerosis	1.29e-05	0.000266	CcSEcCtD
Medroxyprogesterone Acetate—AKR1C3—Signaling Pathways—CXCL13—multiple sclerosis	1.29e-05	0.000788	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Signaling Pathways—CCR1—multiple sclerosis	1.29e-05	0.000788	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Generic Transcription Pathway—PGR—multiple sclerosis	1.29e-05	0.000788	CbGpPWpGaD
Medroxyprogesterone Acetate—Nervous system disorder—Methotrexate—multiple sclerosis	1.29e-05	0.000264	CcSEcCtD
Medroxyprogesterone Acetate—Thrombocytopenia—Methotrexate—multiple sclerosis	1.28e-05	0.000264	CcSEcCtD
Medroxyprogesterone Acetate—Gastrointestinal pain—Prednisone—multiple sclerosis	1.28e-05	0.000264	CcSEcCtD
Medroxyprogesterone Acetate—Nausea—Prednisolone—multiple sclerosis	1.28e-05	0.000264	CcSEcCtD
Medroxyprogesterone Acetate—Pruritus—Betamethasone—multiple sclerosis	1.27e-05	0.000262	CcSEcCtD
Medroxyprogesterone Acetate—Pruritus—Dexamethasone—multiple sclerosis	1.27e-05	0.000262	CcSEcCtD
Medroxyprogesterone Acetate—Skin disorder—Methotrexate—multiple sclerosis	1.27e-05	0.000262	CcSEcCtD
Medroxyprogesterone Acetate—NR3C1—Generic Transcription Pathway—PGR—multiple sclerosis	1.27e-05	0.000776	CbGpPWpGaD
Medroxyprogesterone Acetate—Hyperhidrosis—Methotrexate—multiple sclerosis	1.27e-05	0.000261	CcSEcCtD
Medroxyprogesterone Acetate—Vomiting—Triamcinolone—multiple sclerosis	1.26e-05	0.000259	CcSEcCtD
Medroxyprogesterone Acetate—CYP2C9—Phase 1 - Functionalization of compounds—POMC—multiple sclerosis	1.26e-05	0.000771	CbGpPWpGaD
Medroxyprogesterone Acetate—Vomiting—Methylprednisolone—multiple sclerosis	1.26e-05	0.000259	CcSEcCtD
Medroxyprogesterone Acetate—Rash—Triamcinolone—multiple sclerosis	1.25e-05	0.000257	CcSEcCtD
Medroxyprogesterone Acetate—Dermatitis—Triamcinolone—multiple sclerosis	1.25e-05	0.000257	CcSEcCtD
Medroxyprogesterone Acetate—Anorexia—Methotrexate—multiple sclerosis	1.25e-05	0.000257	CcSEcCtD
Medroxyprogesterone Acetate—Rash—Methylprednisolone—multiple sclerosis	1.25e-05	0.000257	CcSEcCtD
Medroxyprogesterone Acetate—Dermatitis—Methylprednisolone—multiple sclerosis	1.25e-05	0.000257	CcSEcCtD
Medroxyprogesterone Acetate—Urticaria—Prednisone—multiple sclerosis	1.25e-05	0.000256	CcSEcCtD
Medroxyprogesterone Acetate—Headache—Triamcinolone—multiple sclerosis	1.24e-05	0.000256	CcSEcCtD
Medroxyprogesterone Acetate—Headache—Methylprednisolone—multiple sclerosis	1.24e-05	0.000255	CcSEcCtD
Medroxyprogesterone Acetate—Abdominal pain—Prednisone—multiple sclerosis	1.24e-05	0.000255	CcSEcCtD
Medroxyprogesterone Acetate—Body temperature increased—Prednisone—multiple sclerosis	1.24e-05	0.000255	CcSEcCtD
Medroxyprogesterone Acetate—Diarrhoea—Betamethasone—multiple sclerosis	1.23e-05	0.000253	CcSEcCtD
Medroxyprogesterone Acetate—Diarrhoea—Dexamethasone—multiple sclerosis	1.23e-05	0.000253	CcSEcCtD
Medroxyprogesterone Acetate—Hypotension—Methotrexate—multiple sclerosis	1.22e-05	0.000252	CcSEcCtD
Medroxyprogesterone Acetate—ESR1—AP-1 transcription factor network—IL6—multiple sclerosis	1.21e-05	0.000739	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Disease—CD28—multiple sclerosis	1.21e-05	0.000739	CbGpPWpGaD
Medroxyprogesterone Acetate—Musculoskeletal discomfort—Methotrexate—multiple sclerosis	1.19e-05	0.000246	CcSEcCtD
Medroxyprogesterone Acetate—Dizziness—Dexamethasone—multiple sclerosis	1.19e-05	0.000245	CcSEcCtD
Medroxyprogesterone Acetate—Dizziness—Betamethasone—multiple sclerosis	1.19e-05	0.000245	CcSEcCtD
Medroxyprogesterone Acetate—NR3C1—AP-1 transcription factor network—IL6—multiple sclerosis	1.19e-05	0.000728	CbGpPWpGaD
Medroxyprogesterone Acetate—Insomnia—Methotrexate—multiple sclerosis	1.19e-05	0.000244	CcSEcCtD
Medroxyprogesterone Acetate—HSD3B2—Metabolism—APOE—multiple sclerosis	1.18e-05	0.000721	CbGpPWpGaD
Medroxyprogesterone Acetate—Nausea—Triamcinolone—multiple sclerosis	1.18e-05	0.000242	CcSEcCtD
Medroxyprogesterone Acetate—Paraesthesia—Methotrexate—multiple sclerosis	1.18e-05	0.000242	CcSEcCtD
Medroxyprogesterone Acetate—Nausea—Methylprednisolone—multiple sclerosis	1.18e-05	0.000242	CcSEcCtD
Medroxyprogesterone Acetate—PGR—Signaling Pathways—RGS1—multiple sclerosis	1.17e-05	0.000717	CbGpPWpGaD
Medroxyprogesterone Acetate—Dyspnoea—Methotrexate—multiple sclerosis	1.17e-05	0.00024	CcSEcCtD
Medroxyprogesterone Acetate—AR—Generic Transcription Pathway—VDR—multiple sclerosis	1.17e-05	0.000714	CbGpPWpGaD
Medroxyprogesterone Acetate—Somnolence—Methotrexate—multiple sclerosis	1.17e-05	0.00024	CcSEcCtD
Medroxyprogesterone Acetate—Hypersensitivity—Prednisone—multiple sclerosis	1.16e-05	0.000238	CcSEcCtD
Medroxyprogesterone Acetate—Dyspepsia—Methotrexate—multiple sclerosis	1.15e-05	0.000237	CcSEcCtD
Medroxyprogesterone Acetate—Vomiting—Dexamethasone—multiple sclerosis	1.14e-05	0.000235	CcSEcCtD
Medroxyprogesterone Acetate—Vomiting—Betamethasone—multiple sclerosis	1.14e-05	0.000235	CcSEcCtD
Medroxyprogesterone Acetate—CYP2C9—Metabolism of lipids and lipoproteins—CYP27B1—multiple sclerosis	1.14e-05	0.000699	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C9—Metabolism of lipids and lipoproteins—CYP24A1—multiple sclerosis	1.14e-05	0.000699	CbGpPWpGaD
Medroxyprogesterone Acetate—Decreased appetite—Methotrexate—multiple sclerosis	1.14e-05	0.000234	CcSEcCtD
Medroxyprogesterone Acetate—Rash—Betamethasone—multiple sclerosis	1.14e-05	0.000233	CcSEcCtD
Medroxyprogesterone Acetate—Rash—Dexamethasone—multiple sclerosis	1.14e-05	0.000233	CcSEcCtD
Medroxyprogesterone Acetate—Dermatitis—Betamethasone—multiple sclerosis	1.13e-05	0.000233	CcSEcCtD
Medroxyprogesterone Acetate—Dermatitis—Dexamethasone—multiple sclerosis	1.13e-05	0.000233	CcSEcCtD
Medroxyprogesterone Acetate—AR—Gene Expression—PABPC1—multiple sclerosis	1.13e-05	0.000693	CbGpPWpGaD
Medroxyprogesterone Acetate—Gastrointestinal disorder—Methotrexate—multiple sclerosis	1.13e-05	0.000233	CcSEcCtD
Medroxyprogesterone Acetate—Fatigue—Methotrexate—multiple sclerosis	1.13e-05	0.000232	CcSEcCtD
Medroxyprogesterone Acetate—AR—Integrated Breast Cancer Pathway—MYC—multiple sclerosis	1.13e-05	0.00069	CbGpPWpGaD
Medroxyprogesterone Acetate—Headache—Dexamethasone—multiple sclerosis	1.13e-05	0.000232	CcSEcCtD
Medroxyprogesterone Acetate—Headache—Betamethasone—multiple sclerosis	1.13e-05	0.000232	CcSEcCtD
Medroxyprogesterone Acetate—ESR1—Gene Expression—ZFP36L1—multiple sclerosis	1.13e-05	0.000689	CbGpPWpGaD
Medroxyprogesterone Acetate—Asthenia—Prednisone—multiple sclerosis	1.13e-05	0.000231	CcSEcCtD
Medroxyprogesterone Acetate—AKR1C3—Metabolism of lipids and lipoproteins—POMC—multiple sclerosis	1.12e-05	0.000687	CbGpPWpGaD
Medroxyprogesterone Acetate—PGR—Signaling Pathways—GPR65—multiple sclerosis	1.11e-05	0.00068	CbGpPWpGaD
Medroxyprogesterone Acetate—Pruritus—Prednisone—multiple sclerosis	1.11e-05	0.000228	CcSEcCtD
Medroxyprogesterone Acetate—NR3C1—Gene Expression—ZFP36L1—multiple sclerosis	1.11e-05	0.000678	CbGpPWpGaD
Medroxyprogesterone Acetate—PGR—Signaling by ERBB4—IL6—multiple sclerosis	1.11e-05	0.000677	CbGpPWpGaD
Medroxyprogesterone Acetate—AR—Integrated Breast Cancer Pathway—MAPK1—multiple sclerosis	1.1e-05	0.000675	CbGpPWpGaD
Medroxyprogesterone Acetate—Feeling abnormal—Methotrexate—multiple sclerosis	1.08e-05	0.000222	CcSEcCtD
Medroxyprogesterone Acetate—Diarrhoea—Prednisone—multiple sclerosis	1.07e-05	0.000221	CcSEcCtD
Medroxyprogesterone Acetate—Gastrointestinal pain—Methotrexate—multiple sclerosis	1.07e-05	0.00022	CcSEcCtD
Medroxyprogesterone Acetate—NR3C1—SIDS Susceptibility Pathways—IL1B—multiple sclerosis	1.07e-05	0.000655	CbGpPWpGaD
Medroxyprogesterone Acetate—Nausea—Betamethasone—multiple sclerosis	1.07e-05	0.00022	CcSEcCtD
Medroxyprogesterone Acetate—Nausea—Dexamethasone—multiple sclerosis	1.07e-05	0.00022	CcSEcCtD
Medroxyprogesterone Acetate—ESR1—Signaling Pathways—LINGO1—multiple sclerosis	1.07e-05	0.000653	CbGpPWpGaD
Medroxyprogesterone Acetate—NR3C1—Glucocorticoid receptor regulatory network—IL6—multiple sclerosis	1.05e-05	0.000641	CbGpPWpGaD
Medroxyprogesterone Acetate—Urticaria—Methotrexate—multiple sclerosis	1.04e-05	0.000214	CcSEcCtD
Medroxyprogesterone Acetate—NR3C1—Adipogenesis—STAT3—multiple sclerosis	1.04e-05	0.000635	CbGpPWpGaD
Medroxyprogesterone Acetate—Dizziness—Prednisone—multiple sclerosis	1.04e-05	0.000213	CcSEcCtD
Medroxyprogesterone Acetate—Abdominal pain—Methotrexate—multiple sclerosis	1.04e-05	0.000213	CcSEcCtD
Medroxyprogesterone Acetate—Body temperature increased—Methotrexate—multiple sclerosis	1.04e-05	0.000213	CcSEcCtD
Medroxyprogesterone Acetate—CYP3A4—Cytochrome P450 - arranged by substrate type—POMC—multiple sclerosis	1.03e-05	0.000627	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Metabolism of lipids and lipoproteins—ALB—multiple sclerosis	1.02e-05	0.000626	CbGpPWpGaD
Medroxyprogesterone Acetate—AR—SIDS Susceptibility Pathways—TNF—multiple sclerosis	1.02e-05	0.000626	CbGpPWpGaD
Medroxyprogesterone Acetate—AR—Gene Expression—RPL5—multiple sclerosis	1.02e-05	0.000625	CbGpPWpGaD
Medroxyprogesterone Acetate—PGR—Signaling Pathways—CCR1—multiple sclerosis	1.02e-05	0.000622	CbGpPWpGaD
Medroxyprogesterone Acetate—PGR—Signaling Pathways—CXCL13—multiple sclerosis	1.02e-05	0.000622	CbGpPWpGaD
Medroxyprogesterone Acetate—HSD3B2—Metabolism—POMC—multiple sclerosis	1.01e-05	0.000619	CbGpPWpGaD
Medroxyprogesterone Acetate—Vomiting—Prednisone—multiple sclerosis	9.97e-06	0.000205	CcSEcCtD
Medroxyprogesterone Acetate—Rash—Prednisone—multiple sclerosis	9.89e-06	0.000203	CcSEcCtD
Medroxyprogesterone Acetate—Dermatitis—Prednisone—multiple sclerosis	9.88e-06	0.000203	CcSEcCtD
Medroxyprogesterone Acetate—Headache—Prednisone—multiple sclerosis	9.82e-06	0.000202	CcSEcCtD
Medroxyprogesterone Acetate—AKR1C3—Metabolism—BCHE—multiple sclerosis	9.68e-06	0.000592	CbGpPWpGaD
Medroxyprogesterone Acetate—Hypersensitivity—Methotrexate—multiple sclerosis	9.66e-06	0.000199	CcSEcCtD
Medroxyprogesterone Acetate—NR3C1—Adipogenesis—TGFB1—multiple sclerosis	9.62e-06	0.000588	CbGpPWpGaD
Medroxyprogesterone Acetate—Asthenia—Methotrexate—multiple sclerosis	9.4e-06	0.000193	CcSEcCtD
Medroxyprogesterone Acetate—AR—Integrated Pancreatic Cancer Pathway—MYC—multiple sclerosis	9.35e-06	0.000572	CbGpPWpGaD
Medroxyprogesterone Acetate—AR—Integrated Pancreatic Cancer Pathway—TGFB1—multiple sclerosis	9.33e-06	0.00057	CbGpPWpGaD
Medroxyprogesterone Acetate—Nausea—Prednisone—multiple sclerosis	9.31e-06	0.000192	CcSEcCtD
Medroxyprogesterone Acetate—Pruritus—Methotrexate—multiple sclerosis	9.27e-06	0.000191	CcSEcCtD
Medroxyprogesterone Acetate—ESR1—Signaling Pathways—TAGAP—multiple sclerosis	9.26e-06	0.000566	CbGpPWpGaD
Medroxyprogesterone Acetate—HSD3B2—Metabolism—ALB—multiple sclerosis	9.24e-06	0.000565	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Signaling Pathways—CCL3—multiple sclerosis	9.19e-06	0.000562	CbGpPWpGaD
Medroxyprogesterone Acetate—AR—Integrated Pancreatic Cancer Pathway—MAPK1—multiple sclerosis	9.14e-06	0.000559	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Generic Transcription Pathway—VDR—multiple sclerosis	9e-06	0.00055	CbGpPWpGaD
Medroxyprogesterone Acetate—NR3C1—Adipogenesis—TNF—multiple sclerosis	8.99e-06	0.00055	CbGpPWpGaD
Medroxyprogesterone Acetate—Diarrhoea—Methotrexate—multiple sclerosis	8.97e-06	0.000184	CcSEcCtD
Medroxyprogesterone Acetate—CYP2C8—Metabolism—SRM—multiple sclerosis	8.88e-06	0.000543	CbGpPWpGaD
Medroxyprogesterone Acetate—NR3C1—Generic Transcription Pathway—VDR—multiple sclerosis	8.86e-06	0.000542	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Signaling Pathways—PTGER4—multiple sclerosis	8.84e-06	0.000541	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Gene Expression—PABPC1—multiple sclerosis	8.73e-06	0.000534	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Signaling Pathways—PGR—multiple sclerosis	8.71e-06	0.000532	CbGpPWpGaD
Medroxyprogesterone Acetate—AR—Integrated Pancreatic Cancer Pathway—TNF—multiple sclerosis	8.71e-06	0.000532	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Integrated Breast Cancer Pathway—MYC—multiple sclerosis	8.69e-06	0.000531	CbGpPWpGaD
Medroxyprogesterone Acetate—Dizziness—Methotrexate—multiple sclerosis	8.67e-06	0.000178	CcSEcCtD
Medroxyprogesterone Acetate—AKR1C3—Disease—CD86—multiple sclerosis	8.62e-06	0.000527	CbGpPWpGaD
Medroxyprogesterone Acetate—NR3C1—Gene Expression—PABPC1—multiple sclerosis	8.6e-06	0.000526	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Signaling Pathways—CXCR3—multiple sclerosis	8.54e-06	0.000522	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Integrated Breast Cancer Pathway—MAPK1—multiple sclerosis	8.5e-06	0.00052	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Signaling Pathways—CD28—multiple sclerosis	8.46e-06	0.000517	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling by ERBB4—MAPK1—multiple sclerosis	8.46e-06	0.000517	CbGpPWpGaD
Medroxyprogesterone Acetate—Vomiting—Methotrexate—multiple sclerosis	8.33e-06	0.000171	CcSEcCtD
Medroxyprogesterone Acetate—CYP3A4—Phase 1 - Functionalization of compounds—POMC—multiple sclerosis	8.31e-06	0.000508	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Signaling Pathways—CCR2—multiple sclerosis	8.31e-06	0.000508	CbGpPWpGaD
Medroxyprogesterone Acetate—Rash—Methotrexate—multiple sclerosis	8.26e-06	0.00017	CcSEcCtD
Medroxyprogesterone Acetate—AR—SIDS Susceptibility Pathways—IL6—multiple sclerosis	8.26e-06	0.000505	CbGpPWpGaD
Medroxyprogesterone Acetate—Dermatitis—Methotrexate—multiple sclerosis	8.26e-06	0.00017	CcSEcCtD
Medroxyprogesterone Acetate—CYP2C8—Biological oxidations—POMC—multiple sclerosis	8.23e-06	0.000503	CbGpPWpGaD
Medroxyprogesterone Acetate—Headache—Methotrexate—multiple sclerosis	8.21e-06	0.000169	CcSEcCtD
Medroxyprogesterone Acetate—ESR1—Signaling Pathways—S1PR1—multiple sclerosis	8.1e-06	0.000495	CbGpPWpGaD
Medroxyprogesterone Acetate—AR—Gene Expression—PGR—multiple sclerosis	8.05e-06	0.000492	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Gene Expression—RPL5—multiple sclerosis	7.88e-06	0.000482	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling Pathways—GPC5—multiple sclerosis	7.88e-06	0.000482	CbGpPWpGaD
Medroxyprogesterone Acetate—Nausea—Methotrexate—multiple sclerosis	7.78e-06	0.00016	CcSEcCtD
Medroxyprogesterone Acetate—NR3C1—SIDS Susceptibility Pathways—TNF—multiple sclerosis	7.77e-06	0.000475	CbGpPWpGaD
Medroxyprogesterone Acetate—NR3C1—Gene Expression—RPL5—multiple sclerosis	7.76e-06	0.000474	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Signaling Pathways—CNR1—multiple sclerosis	7.67e-06	0.000469	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Disease—CCR5—multiple sclerosis	7.65e-06	0.000467	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Disease—HLA-A—multiple sclerosis	7.45e-06	0.000456	CbGpPWpGaD
Medroxyprogesterone Acetate—PGR—Gene Expression—VDR—multiple sclerosis	7.38e-06	0.000451	CbGpPWpGaD
Medroxyprogesterone Acetate—NR3C1—Adipogenesis—IL6—multiple sclerosis	7.25e-06	0.000443	CbGpPWpGaD
Medroxyprogesterone Acetate—PGR—Signaling Pathways—CCL3—multiple sclerosis	7.25e-06	0.000443	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C9—Metabolism—SRM—multiple sclerosis	7.22e-06	0.000442	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Integrated Pancreatic Cancer Pathway—MYC—multiple sclerosis	7.2e-06	0.00044	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Integrated Pancreatic Cancer Pathway—TGFB1—multiple sclerosis	7.18e-06	0.000439	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Integrated Pancreatic Cancer Pathway—MAPK1—multiple sclerosis	7.04e-06	0.000431	CbGpPWpGaD
Medroxyprogesterone Acetate—PGR—Signaling Pathways—PTGER4—multiple sclerosis	6.98e-06	0.000427	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Disease—APOE—multiple sclerosis	6.96e-06	0.000425	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Signaling Pathways—CXCL10—multiple sclerosis	6.9e-06	0.000422	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling Pathways—RGS1—multiple sclerosis	6.88e-06	0.000421	CbGpPWpGaD
Medroxyprogesterone Acetate—PGR—Signaling Pathways—CXCR3—multiple sclerosis	6.74e-06	0.000412	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Integrated Pancreatic Cancer Pathway—TNF—multiple sclerosis	6.71e-06	0.00041	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C9—Biological oxidations—POMC—multiple sclerosis	6.7e-06	0.000409	CbGpPWpGaD
Medroxyprogesterone Acetate—PGR—Signaling Pathways—CD28—multiple sclerosis	6.67e-06	0.000408	CbGpPWpGaD
Medroxyprogesterone Acetate—PGR—Signaling Pathways—CCR2—multiple sclerosis	6.55e-06	0.000401	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling Pathways—GPR65—multiple sclerosis	6.53e-06	0.000399	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling by ERBB4—IL6—multiple sclerosis	6.5e-06	0.000397	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Disease—CD80—multiple sclerosis	6.29e-06	0.000385	CbGpPWpGaD
Medroxyprogesterone Acetate—NR3C1—SIDS Susceptibility Pathways—IL6—multiple sclerosis	6.27e-06	0.000383	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C8—Metabolism—CYP27B1—multiple sclerosis	6.25e-06	0.000382	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C8—Metabolism—CYP24A1—multiple sclerosis	6.25e-06	0.000382	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Gene Expression—PGR—multiple sclerosis	6.2e-06	0.000379	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C8—Metabolism of lipids and lipoproteins—BCHE—multiple sclerosis	6.11e-06	0.000374	CbGpPWpGaD
Medroxyprogesterone Acetate—NR3C1—Gene Expression—PGR—multiple sclerosis	6.11e-06	0.000373	CbGpPWpGaD
Medroxyprogesterone Acetate—PGR—Generic Transcription Pathway—MYC—multiple sclerosis	6.09e-06	0.000373	CbGpPWpGaD
Medroxyprogesterone Acetate—PGR—Signaling Pathways—CNR1—multiple sclerosis	6.05e-06	0.00037	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Signaling Pathways—CD86—multiple sclerosis	6.04e-06	0.000369	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling Pathways—CXCL13—multiple sclerosis	5.97e-06	0.000365	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling Pathways—CCR1—multiple sclerosis	5.97e-06	0.000365	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Signaling Pathways—CCL5—multiple sclerosis	5.94e-06	0.000363	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Metabolism—APOE—multiple sclerosis	5.82e-06	0.000356	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C8—Metabolism—GPC5—multiple sclerosis	5.72e-06	0.00035	CbGpPWpGaD
Medroxyprogesterone Acetate—AR—Gene Expression—VDR—multiple sclerosis	5.62e-06	0.000344	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Signaling Pathways—SPP1—multiple sclerosis	5.5e-06	0.000337	CbGpPWpGaD
Medroxyprogesterone Acetate—PGR—Signaling Pathways—CXCL10—multiple sclerosis	5.45e-06	0.000333	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Signaling Pathways—CCR5—multiple sclerosis	5.35e-06	0.000327	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Disease—TYK2—multiple sclerosis	5.31e-06	0.000325	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Signaling Pathways—IL2RA—multiple sclerosis	5.28e-06	0.000323	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C9—Metabolism—CYP24A1—multiple sclerosis	5.09e-06	0.000311	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C9—Metabolism—CYP27B1—multiple sclerosis	5.09e-06	0.000311	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Metabolism—POMC—multiple sclerosis	5e-06	0.000306	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C9—Metabolism of lipids and lipoproteins—BCHE—multiple sclerosis	4.98e-06	0.000304	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Signaling Pathways—APOE—multiple sclerosis	4.87e-06	0.000298	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Disease—CD4—multiple sclerosis	4.8e-06	0.000294	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP3A4—Metabolism—SRM—multiple sclerosis	4.76e-06	0.000291	CbGpPWpGaD
Medroxyprogesterone Acetate—PGR—Signaling Pathways—CD86—multiple sclerosis	4.76e-06	0.000291	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C8—Metabolism—RRM1—multiple sclerosis	4.74e-06	0.00029	CbGpPWpGaD
Medroxyprogesterone Acetate—PGR—Signaling Pathways—CCL5—multiple sclerosis	4.69e-06	0.000287	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C9—Metabolism—GPC5—multiple sclerosis	4.66e-06	0.000285	CbGpPWpGaD
Medroxyprogesterone Acetate—AR—Generic Transcription Pathway—MYC—multiple sclerosis	4.64e-06	0.000284	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Metabolism—ALB—multiple sclerosis	4.56e-06	0.000279	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP3A4—Biological oxidations—POMC—multiple sclerosis	4.42e-06	0.00027	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Signaling Pathways—CD80—multiple sclerosis	4.4e-06	0.000269	CbGpPWpGaD
Medroxyprogesterone Acetate—PGR—Signaling Pathways—SPP1—multiple sclerosis	4.34e-06	0.000265	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Gene Expression—VDR—multiple sclerosis	4.33e-06	0.000265	CbGpPWpGaD
Medroxyprogesterone Acetate—NR3C1—Gene Expression—VDR—multiple sclerosis	4.27e-06	0.000261	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling Pathways—CCL3—multiple sclerosis	4.25e-06	0.00026	CbGpPWpGaD
Medroxyprogesterone Acetate—PGR—Signaling Pathways—CCR5—multiple sclerosis	4.22e-06	0.000258	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Signaling Pathways—POMC—multiple sclerosis	4.18e-06	0.000256	CbGpPWpGaD
Medroxyprogesterone Acetate—PGR—Signaling Pathways—IL2RA—multiple sclerosis	4.16e-06	0.000254	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling Pathways—PTGER4—multiple sclerosis	4.09e-06	0.00025	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Signaling Pathways—CCL2—multiple sclerosis	4.09e-06	0.00025	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling Pathways—PGR—multiple sclerosis	4.03e-06	0.000247	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling Pathways—CXCR3—multiple sclerosis	3.95e-06	0.000242	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling Pathways—CD28—multiple sclerosis	3.92e-06	0.000239	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C9—Metabolism—RRM1—multiple sclerosis	3.86e-06	0.000236	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling Pathways—CCR2—multiple sclerosis	3.85e-06	0.000235	CbGpPWpGaD
Medroxyprogesterone Acetate—PGR—Signaling Pathways—APOE—multiple sclerosis	3.84e-06	0.000235	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Signaling Pathways—TYK2—multiple sclerosis	3.72e-06	0.000227	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Disease—STAT3—multiple sclerosis	3.72e-06	0.000227	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C8—Metabolism of lipids and lipoproteins—APOE—multiple sclerosis	3.68e-06	0.000225	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Generic Transcription Pathway—MYC—multiple sclerosis	3.58e-06	0.000219	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling Pathways—CNR1—multiple sclerosis	3.55e-06	0.000217	CbGpPWpGaD
Medroxyprogesterone Acetate—NR3C1—Generic Transcription Pathway—MYC—multiple sclerosis	3.52e-06	0.000215	CbGpPWpGaD
Medroxyprogesterone Acetate—PGR—Signaling Pathways—CD80—multiple sclerosis	3.47e-06	0.000212	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Disease—MYC—multiple sclerosis	3.45e-06	0.000211	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Disease—TGFB1—multiple sclerosis	3.45e-06	0.000211	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Disease—MAPK1—multiple sclerosis	3.38e-06	0.000207	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP3A4—Metabolism—CYP27B1—multiple sclerosis	3.36e-06	0.000205	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP3A4—Metabolism—CYP24A1—multiple sclerosis	3.36e-06	0.000205	CbGpPWpGaD
Medroxyprogesterone Acetate—PGR—Signaling Pathways—POMC—multiple sclerosis	3.3e-06	0.000202	CbGpPWpGaD
Medroxyprogesterone Acetate—PGR—Signaling Pathways—CCL2—multiple sclerosis	3.23e-06	0.000197	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling Pathways—CXCL10—multiple sclerosis	3.2e-06	0.000195	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C8—Metabolism of lipids and lipoproteins—POMC—multiple sclerosis	3.16e-06	0.000193	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Signaling Pathways—IL2—multiple sclerosis	3.09e-06	0.000189	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP3A4—Metabolism—GPC5—multiple sclerosis	3.07e-06	0.000188	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C9—Metabolism of lipids and lipoproteins—APOE—multiple sclerosis	2.99e-06	0.000183	CbGpPWpGaD
Medroxyprogesterone Acetate—PGR—Gene Expression—MYC—multiple sclerosis	2.93e-06	0.000179	CbGpPWpGaD
Medroxyprogesterone Acetate—PGR—Signaling Pathways—TYK2—multiple sclerosis	2.93e-06	0.000179	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Signaling Pathways—MMP9—multiple sclerosis	2.93e-06	0.000179	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C8—Metabolism of lipids and lipoproteins—ALB—multiple sclerosis	2.88e-06	0.000176	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling Pathways—CD86—multiple sclerosis	2.79e-06	0.000171	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling Pathways—CCL5—multiple sclerosis	2.75e-06	0.000168	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C8—Metabolism—BCHE—multiple sclerosis	2.72e-06	0.000166	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Signaling Pathways—STAT3—multiple sclerosis	2.6e-06	0.000159	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Disease—IL6—multiple sclerosis	2.6e-06	0.000159	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C9—Metabolism of lipids and lipoproteins—POMC—multiple sclerosis	2.57e-06	0.000157	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling Pathways—SPP1—multiple sclerosis	2.55e-06	0.000156	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP3A4—Metabolism—RRM1—multiple sclerosis	2.54e-06	0.000156	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling Pathways—CCR5—multiple sclerosis	2.48e-06	0.000152	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling Pathways—IL2RA—multiple sclerosis	2.44e-06	0.000149	CbGpPWpGaD
Medroxyprogesterone Acetate—PGR—Signaling Pathways—IL2—multiple sclerosis	2.44e-06	0.000149	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Signaling Pathways—MYC—multiple sclerosis	2.42e-06	0.000148	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Signaling Pathways—TGFB1—multiple sclerosis	2.41e-06	0.000148	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Signaling Pathways—MAPK1—multiple sclerosis	2.37e-06	0.000145	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C9—Metabolism of lipids and lipoproteins—ALB—multiple sclerosis	2.34e-06	0.000143	CbGpPWpGaD
Medroxyprogesterone Acetate—PGR—Signaling Pathways—MMP9—multiple sclerosis	2.31e-06	0.000141	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling Pathways—APOE—multiple sclerosis	2.25e-06	0.000138	CbGpPWpGaD
Medroxyprogesterone Acetate—AR—Gene Expression—MYC—multiple sclerosis	2.24e-06	0.000137	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C9—Metabolism—BCHE—multiple sclerosis	2.22e-06	0.000135	CbGpPWpGaD
Medroxyprogesterone Acetate—PGR—Signaling Pathways—STAT3—multiple sclerosis	2.05e-06	0.000126	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling Pathways—CD80—multiple sclerosis	2.04e-06	0.000125	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling Pathways—POMC—multiple sclerosis	1.94e-06	0.000118	CbGpPWpGaD
Medroxyprogesterone Acetate—PGR—Signaling Pathways—MYC—multiple sclerosis	1.91e-06	0.000117	CbGpPWpGaD
Medroxyprogesterone Acetate—PGR—Signaling Pathways—TGFB1—multiple sclerosis	1.9e-06	0.000116	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling Pathways—CCL2—multiple sclerosis	1.9e-06	0.000116	CbGpPWpGaD
Medroxyprogesterone Acetate—PGR—Signaling Pathways—MAPK1—multiple sclerosis	1.87e-06	0.000114	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Signaling Pathways—IL6—multiple sclerosis	1.82e-06	0.000111	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Gene Expression—MYC—multiple sclerosis	1.72e-06	0.000105	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling Pathways—TYK2—multiple sclerosis	1.72e-06	0.000105	CbGpPWpGaD
Medroxyprogesterone Acetate—NR3C1—Gene Expression—MYC—multiple sclerosis	1.7e-06	0.000104	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C8—Metabolism—APOE—multiple sclerosis	1.64e-06	0.0001	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP3A4—Metabolism—BCHE—multiple sclerosis	1.46e-06	8.93e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—PGR—Signaling Pathways—IL6—multiple sclerosis	1.43e-06	8.77e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling Pathways—IL2—multiple sclerosis	1.43e-06	8.76e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C8—Metabolism—POMC—multiple sclerosis	1.41e-06	8.6e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling Pathways—MMP9—multiple sclerosis	1.36e-06	8.29e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C9—Metabolism—APOE—multiple sclerosis	1.33e-06	8.15e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C8—Metabolism—ALB—multiple sclerosis	1.28e-06	7.84e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling Pathways—STAT3—multiple sclerosis	1.21e-06	7.37e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C9—Metabolism—POMC—multiple sclerosis	1.15e-06	7e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling Pathways—MYC—multiple sclerosis	1.12e-06	6.85e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling Pathways—TGFB1—multiple sclerosis	1.12e-06	6.83e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling Pathways—MAPK1—multiple sclerosis	1.1e-06	6.7e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C9—Metabolism—ALB—multiple sclerosis	1.04e-06	6.38e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP3A4—Metabolism—APOE—multiple sclerosis	8.79e-07	5.37e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling Pathways—IL6—multiple sclerosis	8.42e-07	5.15e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP3A4—Metabolism—POMC—multiple sclerosis	7.55e-07	4.62e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP3A4—Metabolism—ALB—multiple sclerosis	6.88e-07	4.21e-05	CbGpPWpGaD
